A PAUF-neutralizing antibody targets both carcinoma and endothelial cells to impede pancreatic tumor progression and metastasis.

Biochem Biophys Res Commun 2014 Nov 18;454(1):144-50. Epub 2014 Oct 18.

Immunotherapy Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, South Korea; Department of Biological Sciences, Dong-A University, Busan, South Korea. Electronic address:

Pancreatic adenocarcinoma up-regulated factor (PAUF) is expressed in pancreatic ductal adenocarcinoma (PDAC) and plays an important role in tumor progression and metastasis. Here we evaluate the anti-tumor efficacy of a human monoclonal antibody against PAUF, PMAb83, to provide a therapeutic intervention to treat the disease. PMAb83 reduced tumor growth and distant metastasis in orthotopically xenografted mice of human PDAC cells. PMAb83 treatment retarded proliferation along with weakened aggressiveness traits of the carcinoma cells. AKT/β-catenin signaling played a role in the carcinoma cell proliferation and the treated xenograft tumors exhibited reduced levels of β-catenin and cyclin D1. Moreover PMAb83 abrogated the PAUF-induced angiogenic responses of endothelial cells, reducing the density of CD31(+) vessels in the treated tumors. In combination with gemcitabine, PMAb83 conferred enhanced survival of xenografted mice by about twofold compared to gemcitabine alone. Taken together, our findings show that PMAb83 treatment decreases the aggressiveness of carcinoma cells and suppresses tumor vascularization, which culminates in mitigated tumor growth and metastasis with improved survival in PDAC mouse models.

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0006291X140185
Publisher Site
http://dx.doi.org/10.1016/j.bbrc.2014.10.056DOI Listing
November 2014

Publication Analysis

Top Keywords

tumor growth
8
xenografted mice
8
tumor progression
8
progression metastasis
8
carcinoma cells
8
endothelial cells
8
pmab83 treatment
8
pmab83
6
tumor
5
cells
5
vessels treated
4
tumors combination
4
cd31+ vessels
4
mice human
4
treatment retarded
4
human pdac
4
orthotopically xenografted
4
pdac cells
4
treated tumors
4
cells pmab83
4

Similar Publications